Oncothyreon to receive milestone payment from Merck KGaA(16 May 2008)
Oncothyreon Inc. announced that it has completed the transfer of certain assays and manufacturing technology related to Stimuvax(R) (BLP25 liposome vaccine) to Merck KGaA of Darmstadt, Germany, triggering a payment to Oncothyreon of $3 million. ...
Novosom granted US and European patents for RNAi-delivering Smarticles(16 May 2008)
Novosom AG announced that it has been granted patents for both the USA and Europe for its Drug Delivery technology SmarticlesŪ. SmarticlesŪ are fully charge reversible liposomes for the in vivo drug delivery of nucleotides like siRNA or ...
Families shed light on likely causative gene for Alzheimer's(16 May 2008)
The genetic profile of two large Georgia families with high rates of late-onset Alzheimer's disease points to a gene that may cause the disease, researchers say. Genetic variations called single nucleotide polymorphisms, or SNPs, are common in ...
Effects of sticky ends(15 May 2008)
Japanese scientists have investigated the self-assembled synthesis of DNA nanostructures using direct observation of charge transfer kinetics. Tetsuro Majima, Kiyohiko Kawai and colleagues from Osaka University made photosensitizer modified and ...
ORF Genetics Opens 'Green Factory' in Iceland(15 May 2008) Human growth factors produced in barley grain, using renewable, geothermal energy
ORF Genetics, an Icelandic biotechnology company, announced the opening of new 22,000 ft2 (2043m2) cultivation facilities in Grindavik, Iceland. Utilizing its unique Orfeus(TM) protein production system in barley, ORF Genetics produces and ...
QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes(15 May 2008) Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development
QIAGEN and GENEART announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins. According to the company, QIAgenes is the world's first comprehensive set of ...
KINAXO Biotechnologies Enters Agreement with Onconova Therapeutics Inc.(15 May 2008)
KINAXO Biotechnologies announced a cooperation between Oncovova Therapeutics Inc, Newtown, PA, USA and KINAXO Biotechnologies. Onconova Therapeutics is a clinical stage research and development company focused on development of its novel small ...
Top